HomeNDC LookupRxCUI directory › RxCUI 1426600

{24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Chewable Tablet) / 4 (ferrous... — RxCUI 1426600

RxNorm drug concept · Generic pack
RxCUI 1426600 Generic pack · GPCK ● Current RxNorm concept 7 FDA products 7 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1426600
Official name{24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Oral Tablet) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asEth estra-Noreth Ac 0.02-1 MG (24) Chewable Tablet / Ferr fum 75 MG (4) Oral Tablet 28 Day Pack
FDA products mapped7
Package NDCs mapped7
Reported Medicaid activity (SDUD)9,462 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Norethindrone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Most norethindrone tablets — including brands like Camila, Errin, Emzahh, and Affodel — are progestin-only birth control pills taken daily to prevent pre...
  • Regular combination birth control pills contain two hormones — estrogen and progestin. Norethindrone is a progestin-only pill, sometimes called the 'mini-pill.' Because it has no e...
  • How is this different from regular birth control pills?
  • The most common thing people notice is irregular bleeding — spotting between periods, or changes in your cycle. Headache, breast tenderness, nausea, and dizziness are also reported...
📖 Read our full Norethindrone guide →

🕸️ Concept Web — How {24 (ethinyl estradiol 0.02 MG / norethindrone a... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Oral Tablet) } Pack RxCUI 1426600

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Ethinyl estradiol 4124
    • Ferrous fumarate 24941
    • Norethindrone 7514
    • Ethinyl estradiol / norethindrone 384410
    • Norethindrone acetate 31983
  2. Dose forms 15

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ethinyl estradiol / norethindrone Chewable Tablet 446877
    • Ferrous fumarate Oral Tablet 372172
    • Ethinyl estradiol / norethindrone acetate Chewable Tablet 2648716
    • Ethinyl estradiol / norethindrone Chewable Product 1295455
    • Ethinyl estradiol / norethindrone Oral Product 1157354
    • Ethinyl estradiol / norethindrone Pill 1157355
    • Ferrous fumarate Oral Product 1159640
    • Ferrous fumarate Pill 1159641
    • +7 more in this family
  3. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  4. Packs 5

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 23 of 30 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Chewable Tablet SCD · 1426288
  • Ferrous fumarate 75 MG Oral Tablet SCD · 259176
  • Ethinyl estradiol 0.02 MG SCDC · 317366
  • Ferrous fumarate 75 MG SCDC · 358518
  • Norethindrone acetate 1 MG SCDC · 1037182
  • Ethinyl estradiol / norethindrone Chewable Tablet SCDF · 446877
  • Ferrous fumarate Oral Tablet SCDF · 372172
  • Ethinyl estradiol / norethindrone acetate Chewable Tablet SCDFP · 2648716
  • Ethinyl estradiol / norethindrone Chewable Product SCDG · 1295455
  • Ethinyl estradiol / norethindrone Oral Product SCDG · 1157354

📦 FDA Products & Package NDCs

7 products · 7 package NDCs
7 package NDCs map to RxCUI 1426600 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-8210-62 3 POUCH in 1 CARTON (0093-8210-62) / 1 BLISTER PACK in 1 PO... Finzala Teva Pharmaceuticals USA, Inc. 2022-08-04
59651-0504-88 3 POUCH in 1 CARTON (59651-504-88) / 1 BLISTER PACK in 1 PO... OSHIH Aurobindo Pharma Limited 2023-12-06
68180-0911-73 3 POUCH in 1 CARTON (68180-911-73) / 1 BLISTER PACK in 1 PO... Mibelas 24 Fe Lupin Pharmaceuticals, Inc. 2020-03-31
68462-0376-29 3 BLISTER PACK in 1 CARTON (68462-376-29) / 1 KIT in 1 BLIS... norethindrone acetate and ethinyl estradiol and ferrous fumarate Glenmark Pharmaceuticals Inc., USA 2017-12-26
68462-0852-29 3 BLISTER PACK in 1 CARTON (68462-852-29) / 1 KIT in 1 BLIS... Charlotte 24Fe Glenmark Pharmaceuticals Inc., USA 2020-02-20
69238-1031-07 3 BLISTER PACK in 1 CARTON (69238-1031-7) / 1 KIT in 1 BLIS... Melodetta 24 Fe Amneal Pharmaceuticals NY LLC 2017-09-21
70700-0101-85 3 BLISTER PACK in 1 CARTON (70700-101-85) / 1 KIT in 1 BLIS... Norethindrone Acetate and Ethinyl Estradiol Xiromed, LLC 2018-08-24
Observed labelers: Glenmark Pharmaceuticals Inc., USA (2) · Amneal Pharmaceuticals NY LLC (1) · Aurobindo Pharma Limited (1) · Lupin Pharmaceuticals, Inc. (1) · Teva Pharmaceuticals USA, Inc. (1) · Xiromed, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.